Pharmacovigilance is a domain that involves a variety of stakeholders such as pharmaceutical manufacturers, drug marketers, contract research organizations, regulators, healthcare professionals, subject matter experts and the consumers, among others. India is globally recognized as an important hub for generic drug manufacturing and the Indian pharmaceutical industry has carved a niche for itself in exporting its products to many developed as well as emerging countries. Of late, India is also being seen as a target destination for procurement of support services required for the global pharmaceutical industry, with pharmacovigilance outsourcing having grown to an impressive extent in the past decade.
Meanwhile, a revolution may be said to have happened in the Indian pharmacovigilance requirements for the pharmaceutical industry, with the ‘Pharmacovigilance Guidance Document for Marketing Authorization Holders of Pharmaceutical Products’ having been made effective since January 2018, building upon the release of the March 8th 2016 dated gazette notification GSR 287 (E) that made pharmacovigilance a legal mandate for the industry. Hence, it is obvious that understanding the reach and implications of Pharmacovigilance in India is inevitable for all stakeholders, especially manufacturers or importers of drugs.
At this juncture, the task of integrating and streamlining the opinions and expectations of all stakeholders of Indian pharmacovigilance assumes significant relevance. The Indian Pharmacovigilance Day 2018 conference is all set to achieve this formidable goal with immense focus and dedication. During the conference, expert speakers from the industry, health authorities, research bodies, academia and healthcare delivery centres will share their perspectives on the multifaceted outlook of the discipline of pharmacovigilance in India and deliberate on the challenges they expect to face in 2018.
Please click on the conference website https://indianpharmacovigilanceday2018.lsacademyevents.it/ for more information.